- Adults
- General population
- People at high risk of STIs
- PrEP users
- Hospital wide
- Outpatient clinic
- Monkeypox virus
- Monkeypox virus infection
- Pharmacological intervention
- Vaccination
- MVA-BN
Intervention: Pharmacological intervention
This refers to the drug, therapy, or factor being studied in a clinical trial or observational study. Examples include antiviral agents monoclonal antibodies, corticosteroids, vaccines and other pharmacological agents
- Adults
- Elderly
- Fragile population
- Outpatient clinic
- Community
- Non-hospital health centre
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Monoclonal antibodies
- Sotrovimab
- Molnupiravir
- Adults
- General population
- Elderly
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Molnupiravir
- Adults
- General population
- Elderly
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Antivirals
- Plitidepsin
- Adults
- Elderly
- Paediatric
- People at high risk of STIs
- Men who have sex with men
- Healthcare workers
- Hospital wide
- Infectious diseases unit
- Monkeypox virus
- Monkeypox virus infection
- Pharmacological intervention
- Vaccination
- MVA-BN
- Adults
- General population
- Elderly
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Probiotic
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Probiotic
- Adults
- Elderly
- Fragile population
- Paediatric
- Immunocompromised host
- Outpatient clinic
- Community
- Non-hospital health centre
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Monoclonal antibodies
- Sotrovimab
- Adults
- General population
- Elderly
- Monkeypox virus
- Monkeypox virus infection
- Pharmacological intervention
- Antivirals
- Tecovirimat
- Adults
- General population
- Monkeypox virus
- Monkeypox virus infection
- Pharmacological intervention
- Vaccination
- mRNA-1769
- Adults
- General population
- Elderly
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- BC 007
- Adults
- General population
- Monkeypox virus
- Monkeypox virus infection
- Pharmacological intervention
- Vaccination
- BNT166a